Century Therapeutics, Inc.
NASDAQ:IPSC
0.55 (USD) • At close May 2, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 58.441 | 47.324 | 84.265 | 56.445 | 27.211 | 44.064 |
| Short Term Investments
| 130.851 | 125.414 | 231.233 | 166.434 | 48.542 | 37.475 |
| Cash and Short Term Investments
| 189.292 | 172.738 | 315.498 | 222.879 | 75.753 | 81.539 |
| Net Receivables
| 0 | 0 | 0.78 | 0.25 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | -0.25 | 1.88 | 2.336 |
| Other Current Assets
| 0.86 | 4.256 | 3.443 | 5.025 | 3.044 | 2.583 |
| Total Current Assets
| 194.051 | 176.994 | 319.721 | 228.154 | 78.797 | 84.122 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 90.847 | 92.081 | 111.73 | 69.821 | 15.385 | 2.488 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 34.2 | 0 | 0 | 0 | 9.392 | 0 |
| Goodwill and Intangible Assets
| 34.2 | 0 | 0 | 0 | 9.392 | 0 |
| Long Term Investments
| 30.818 | 89.096 | 51.854 | 135.914 | 1.053 | 4.08 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0.909 | 0 |
| Other Non-Current Assets
| 3.3 | 2.52 | 3.239 | 3.486 | 1.24 | 0.206 |
| Total Non-Current Assets
| 159.165 | 183.697 | 166.823 | 209.221 | 27.979 | 6.774 |
| Total Assets
| 353.216 | 360.691 | 486.544 | 437.375 | 106.776 | 90.896 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 3.075 | 2.741 | 5.454 | 7.596 | 8.082 | 1.548 |
| Short Term Debt
| 0 | 1.513 | 6.977 | 1.654 | 0.24 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 109.164 | 4.372 | 7.154 | 5.323 | 3.738 | 0 |
| Other Current Liabilities
| 17.543 | 9.22 | 10.232 | 6.405 | 3.79 | 1.446 |
| Total Current Liabilities
| 129.782 | 17.846 | 29.817 | 15.655 | 12.112 | 2.994 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 46.658 | 42.437 | 23.462 | 21.315 | 0 |
| Deferred Revenue Non-Current
| 0 | 111.381 | 110.834 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 4.374 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 57.698 | 0.056 | 0.718 | 2.02 | 179.761 | 0 |
| Total Non-Current Liabilities
| 62.072 | 158.095 | 153.989 | 25.482 | 201.076 | 179.761 |
| Total Liabilities
| 191.854 | 175.941 | 183.806 | 41.137 | 213.188 | 182.755 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 179.761 | 179.761 |
| Common Stock
| 0.009 | 0.006 | 0.006 | 0.005 | 0.001 | 0.001 |
| Retained Earnings
| -782.337 | -655.771 | -519.098 | -388.166 | -292.342 | -238.767 |
| Accumulated Other Comprehensive Income/Loss
| 0.324 | 0.108 | -2.462 | -0.65 | -0.003 | -0.003 |
| Other Total Stockholders Equity
| 943.366 | 840.407 | 824.292 | 785.049 | 185.932 | 146.911 |
| Total Shareholders Equity
| 161.362 | 184.75 | 302.738 | 396.238 | -106.412 | -91.859 |
| Total Equity
| 161.362 | 184.75 | 302.738 | 396.238 | -106.412 | -91.859 |
| Total Liabilities & Shareholders Equity
| 353.216 | 360.691 | 486.544 | 437.375 | 106.776 | 90.896 |